NCT07035418

Brief Summary

The purpose of this mixed-methods study is to determine Adolescent and Young Adult (AYAs) decision making preferences post cancer diagnosis using vignettes designed to assess their preferred involvement in decisions about their cancer treatment and variables associated with these treatment decision-making (TDM) preferences.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Aug 2022Aug 2026

Study Start

First participant enrolled

August 23, 2022

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

June 6, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 25, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

3.9 years

First QC Date

June 6, 2025

Last Update Submit

February 25, 2026

Conditions

Keywords

CancerSurvivorAdolescent and Young Adults

Outcome Measures

Primary Outcomes (1)

  • Distribution of Decision-Making Roles in Clinical Scenarios

    Proportion of participants who select an active, collaborative, or passive role in hypothetical clinical decision-making scenarios. Each role will be counted and compared across participant subgroups.

    Within 2 weeks of survey link delivery

Secondary Outcomes (3)

  • Association Between Sociodemographic Characteristics and Decision-Making Role

    At time of electronic survey completion

  • Concordance Between Interview Responses and Scenario-Based Decision-Making Roles

    At time of interview, within 4 weeks of survey completion

  • Correlation Between Healthcare Encounters and Decision-Making Role Preference

    At time of interview, within 4 weeks of survey completion

Study Arms (1)

AYA Decision-Making Role Assessment

EXPERIMENTAL

Participants will complete an electronic socio-demographic questionnaire followed by a set of hypothetical clinical decision-making scenarios to assess preferred decision-making roles and involvement of healthcare providers and family/friends. Responses will inform understanding of facilitators and barriers to shared decision-making.

Behavioral: Clinical Decision-Making Scenarios and Preferences Assessment

Interventions

Participants complete a socio-demographic questionnaire and decision-making preferences scale, including hypothetical clinical scenarios, to identify their preferred decision-making role (active, collaborative, or passive) and the influence of providers or family. Delivered electronically via secure link; reminders sent as needed.

AYA Decision-Making Role Assessment

Eligibility Criteria

Age15 Years - 29 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age (15-29 years)
  • Cancer diagnosis and on therapy, end-of-life or survivors (within 1 year)
  • Speaks English
  • Reads English
  • Cognitively and physically able to participate

You may not qualify if:

  • Unable to participate in study due to developmental delay or developmental disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Palo Alto, California, 94304, United States

RECRUITING

MeSH Terms

Conditions

Adolescent BehaviorNeoplasms

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Kimberly Pyke-Grimm

    Stanford University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Swathi Alagandula

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2025

First Posted

June 25, 2025

Study Start

August 23, 2022

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations